154 related articles for article (PubMed ID: 26517961)
41. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression.
Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS
Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700
[TBL] [Abstract][Full Text] [Related]
42. Preparation and biological studies of 125I-DOTA-TATE.
Korde A; Pandey U; Banerjee S; Dev Sarma H; Mukherjee A; Venkatesh M
Appl Radiat Isot; 2007 Jun; 65(6):687-90. PubMed ID: 17137786
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma.
Chezal JM; Papon J; Labarre P; Lartigue C; Galmier MJ; Decombat C; Chavignon O; Maublant J; Teulade JC; Madelmont JC; Moins N
J Med Chem; 2008 Jun; 51(11):3133-44. PubMed ID: 18481842
[TBL] [Abstract][Full Text] [Related]
44. Iodothiouracil as a melanoma localizing agent.
Coderre JA; Packer S; Fairchild RG; Greenberg D; Laster B; Micca P; Fand I
J Nucl Med; 1986 Jul; 27(7):1157-64. PubMed ID: 3723191
[TBL] [Abstract][Full Text] [Related]
45. 131I-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors: loss of tumor specificity due to radiolysis.
DeNardo GL; DeNardo SJ; Wessels BW; Kukis DL; Miyao N; Yuan A
Cancer Biother Radiopharm; 2000 Dec; 15(6):547-60. PubMed ID: 11190487
[TBL] [Abstract][Full Text] [Related]
46. 99mTc(I)/Re(I) tricarbonyl complexes for in vivo targeting of melanotic melanoma: Synthesis and biological evaluation.
Moura C; Gano L; Mendes F; Raposinho PD; Abrantes AM; Botelho MF; Santos I; Paulo A
Eur J Med Chem; 2012 Apr; 50():350-60. PubMed ID: 22397924
[TBL] [Abstract][Full Text] [Related]
47. Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody.
Ghose T; Ferrone S; Imai K; Norvell ST; Luner SJ; Martin RH; Blair AH
J Natl Cancer Inst; 1982 Oct; 69(4):823-6. PubMed ID: 6956760
[TBL] [Abstract][Full Text] [Related]
48. Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin.
Böni R; Steinert H; Böni RA; Lichtensteiger W; Dummer R; Hartman DS; von Schulthess GK; Burg G; Westera G
Dermatology; 1996; 193(3):198-202. PubMed ID: 8944340
[TBL] [Abstract][Full Text] [Related]
49. Non-invasive dynamic assessment of conjunctival melanomas by photoacoustic imaging.
Khattak S; Gupta N; Zhou X; Pires L; Wilson BC; Yucel YH
Exp Eye Res; 2019 Feb; 179():157-167. PubMed ID: 30447197
[TBL] [Abstract][Full Text] [Related]
50. Improved In Vivo Stability of Radioiodinated Rituximab Using an Iodination Linker for Radioimmunotherapy.
Kim EJ; Kim BS; Choi DB; Chi SG; Choi TH
Cancer Biother Radiopharm; 2016 Oct; 31(8):287-294. PubMed ID: 27689933
[TBL] [Abstract][Full Text] [Related]
51. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
[TBL] [Abstract][Full Text] [Related]
52. Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.
Bubeck B; Eisenhut M; Heimke U; zum Winkel K
Eur J Nucl Med; 1981; 6(5):227-33. PubMed ID: 6788553
[TBL] [Abstract][Full Text] [Related]
53. In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule.
Degoul F; Borel M; Jacquemot N; Besse S; Communal Y; Mishellany F; Papon J; Penault-Llorca F; Donnarieix D; Doly M; Maigne L; Miot-Noirault E; Cayre A; Cluzel J; Moins N; Chezal JM; Bonnet M
Int J Cancer; 2013 Sep; 133(5):1042-53. PubMed ID: 23404099
[TBL] [Abstract][Full Text] [Related]
54. Improved detection of regional melanoma metastasis using 18F-6-fluoro-N-[2-(diethylamino)ethyl] pyridine-3-carboxamide, a melanin-specific PET probe, by perilesional administration.
Denoyer D; Potdevin T; Roselt P; Neels OC; Kirby L; Greguric I; Katsifis A; Dorow DS; Hicks RJ
J Nucl Med; 2011 Jan; 52(1):115-22. PubMed ID: 21149487
[TBL] [Abstract][Full Text] [Related]
55. [Perspectives of scintigraphic diagnosis of malignant lymphoma using a new radiopharmaceutical].
Meyniel G; Michelot J; Moreau MF; Veyre A
C R Acad Sci III; 1990; 311(1):13-8. PubMed ID: 2125523
[TBL] [Abstract][Full Text] [Related]
56. Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.
Froidevaux S; Calame-Christe M; Tanner H; Eberle AN
J Nucl Med; 2005 May; 46(5):887-95. PubMed ID: 15872364
[TBL] [Abstract][Full Text] [Related]
57. Potential radiopharmaceuticals for the detection of ocular melanoma. Part I. 5-iodo-2-thiouracil derivatives.
van Langevelde A; Bakker CN; Broxterman HJ; Journée-de Korver JG; Kaspersen FM; Oosterhuis JA; Pauwels EK
Eur J Nucl Med; 1983; 8(2):45-51. PubMed ID: 6840126
[TBL] [Abstract][Full Text] [Related]
58. Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas.
Zhao L; Zhu J; Cheng Y; Xiong Z; Tang Y; Guo L; Shi X; Zhao J
ACS Appl Mater Interfaces; 2015 Sep; 7(35):19798-808. PubMed ID: 26291070
[TBL] [Abstract][Full Text] [Related]
59. Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma.
Howell RC; Revskaya E; Pazo V; Nosanchuk JD; Casadevall A; Dadachova E
Bioconjug Chem; 2007; 18(6):1739-48. PubMed ID: 17907769
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
